Stockreport

Esperion settles patent dispute with Dr. Reddy's over cholesterol drugs [Seeking Alpha]

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors
PDF Reddy's Laboratories ( NYSE: RDY ) regarding the latter's bid to launch generic versions of NEXLETOL and NEXLIZET in the U.S. Under the agreement, Dr. Reddy's will not [Read more]